Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan
Status:
Completed
Trial end date:
2016-11-09
Target enrollment:
Participant gender:
Summary
The objective of this surveillance is to collect information about 1) adverse drug reaction
not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug
reactions in this surveillance, and 3)factors considered to affect the safety and/or efficacy
of this drug.